CY-1899

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 05:11:20 GMT 2023` Edited by `admin` on `Sat Dec 16 05:11:20 GMT 2023`
Protein Type	VACCINE ANTIGEN
Protein Sub Type	T-CELL ANTIGEN
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	HM7AT2E2B6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CY-1899

Code

English

IMMUNOTHERAPEUTIC VACCINE CONSISTING OF (PAM)2-LYS-SER-SER-GLN-TYR-ILE-LYS-ALA-ASN-SER-LYS-PHE-ILE-GLY-ILE-THR-GLU-ALA-ALA-ALA-PHE-LEU-PRO-SER-ASP-PHE-PHE-PRO-SER-VAL

Common Name

English

L-Valine, N2,N6-bis(1-oxohexadecyl)-L-lysyl-L-seryl-L-seryl-L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-α-glutamyl-L-alanyl-L-alanyl-L-alanyl-L-phenylalanyl-

Systematic Name

English

CY 1899 [WHO-DD]

Common Name

English

THERADIGM HBV

Common Name

English

CY1899

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

74893

Created by admin on Sat Dec 16 05:11:20 GMT 2023 , Edited by admin on Sat Dec 16 05:11:20 GMT 2023

Code System Code Type Description

CAS

186511-30-8

Created by admin on Sat Dec 16 05:11:20 GMT 2023 , Edited by admin on Sat Dec 16 05:11:20 GMT 2023

PRIMARY

FDA UNII

HM7AT2E2B6

Created by admin on Sat Dec 16 05:11:20 GMT 2023 , Edited by admin on Sat Dec 16 05:11:20 GMT 2023

PRIMARY

Related Record Type Details


					77H9EM77P7

HEPATITIS B VIRUS

TARGET ORGANISM->VACCINE ANTIGEN

Comments:

T-cell antigen

Amount:


					84G53YZS9Y

Hepatitis B capsid protein

TARGET->ANTIGEN

Comments:

T-cell antigen

Amount:

Related Record Type Details


					HM7AT2E2B6

CY-1899

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL